Cargando…

Correction: Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855395/ https://www.ncbi.nlm.nih.gov/pubmed/29523574 http://dx.doi.org/10.1136/bmjopen-2017-016700corr1

Ejemplares similares

Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia
por: Canfell, Karen, et al.
Publicado: (2018)

Correction: An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway
Publicado: (2019)

Health consciousness and cervical cancer screening rates in HPV-unvaccinated girls: comparison from HPV-recommended and HPV-recommendation-suspended program periods
por: Miyoshi, Ai, et al.
Publicado: (2020)

Author Correction: Sexual practices and HPV infection in unvaccinated young adults
por: Pauli, Sílvia, et al.
Publicado: (2022)

Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden
por: Fogelberg, Sara, et al.
Publicado: (2020)

Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting
por: Kotaniemi-Talonen, L, et al.
Publicado: (2005)

High Prevalence of HPV 51 in an Unvaccinated Population and Implications for HPV Vaccines
por: Bowden, Sarah J., et al.
Publicado: (2022)

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial
por: Canfell, Karen, et al.
Publicado: (2017)

Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia
por: Smith, Megan A., et al.
Publicado: (2017)

Shifting from cytology to HPV testing for cervical cancer screening in Canada
por: Delpero, Emily, et al.
Publicado: (2022)

HPV-genotyping versus conventional cervical cytology as a screening method to detect dysplastic cervical epithelial changes
por: Abbas, Mahmoud, et al.
Publicado: (2022)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

Cervical Cancer Screening in Low Resource Settings: Cytology versus HPV Triage for VIA Positive Women
por: Mishra, Gauravi A., et al.
Publicado: (2019)

The prevalence of 30 HPV genotypes detected by EUROArray HPV in cervical samples among unvaccinated women from Vojvodina province, Serbia
por: Kovacevic, Gordana, et al.
Publicado: (2021)

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial – the HPV FOCAL Study
por: Ogilvie, G S, et al.
Publicado: (2012)

HPV-specific risk assessment of cervical cytological abnormalities
por: Zhong, Guanglei, et al.
Publicado: (2021)

Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytology
por: Termrungruanglert, Wichai, et al.
Publicado: (2018)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening
por: Hashim, Dana, et al.
Publicado: (2020)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

Correction: Transmission reduction and prevention with HPV vaccination (TRAP-HPV) study protocol: a randomised controlled trial of the efficacy of HPV vaccination in preventing transmission of HPV infection in heterosexual couples
Publicado: (2020)

Correction: Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
por: Avian, Alice, et al.
Publicado: (2023)

Sexual practices and HPV infection in unvaccinated young adults
por: Pauli, Sílvia, et al.
Publicado: (2022)

The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening
por: Aitken, Clare A, et al.
Publicado: (2019)

Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies
por: Pista, Angela, et al.
Publicado: (2019)

HPV molecular detection from urine versus cervical samples: an alternative for HPV screening in indigenous populations
por: Torres-Rojas, Francisco I., et al.
Publicado: (2021)

High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology
por: Crawford, Robin, et al.
Publicado: (2011)

Cost-Effectiveness of Primary HPV Screening Strategies and Triage With Cytology or Dual Stain for Cervical Cancer
por: Tantitamit, Tanitra, et al.
Publicado: (2020)

Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program
por: Onuki, Mamiko, et al.
Publicado: (2022)

Analysis of cervical HPV infections among unvaccinated young adult women to inform vaccine strategies in this age group: the Costa Rica HPV Vaccine Trial
por: Sierra, Mónica S., et al.
Publicado: (2023)

Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia
por: Hall, Michaela T., et al.
Publicado: (2018)

National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study
por: Smith, Megan A, et al.
Publicado: (2022)

Cervical cytological abnormalities and HPV infection in perinatally HIV–infected adolescents
por: Ananworanich, J, et al.
Publicado: (2015)

HPV prevalence and type distribution in Cypriot women with cervical cytological abnormalities
por: Krashias, George, et al.
Publicado: (2017)

High-Risk HPV Genotype Distribution According to Cervical Cytology and Age
por: Trama, Jason P, et al.
Publicado: (2022)

HPV and cervical cancer: screening or vaccination?
por: Bosch, F X, et al.
Publicado: (2008)

An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway
por: Enerly, Espen, et al.
Publicado: (2019)

Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16(INK4a) immunostaining in China
por: Song, Fangbin, et al.
Publicado: (2021)

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence
por: Arbyn, Marc, et al.
Publicado: (2020)

Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing
por: Vassilakos, P, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_p23lst3fpiqrsg58us35g7jbg3